PMC:7652766 / 111625-111854 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7652766","sourcedb":"PMC","sourceid":"7652766","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7652766","text":"gy and efficiently reducing MERS-CoV replication.\nOriginally developed as an antiprotozoal agent, nitazoxanide is another broad-spectrum antiviral agent that has been currently developed to treat influenza and other viral respira","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"4109","span":{"begin":28,"end":36},"obj":"Species"},{"id":"4124","span":{"begin":187,"end":189},"obj":"Gene"},{"id":"4126","span":{"begin":196,"end":205},"obj":"Species"},{"id":"4127","span":{"begin":98,"end":110},"obj":"Chemical"}],"attributes":[{"id":"A4109","pred":"tao:has_database_id","subj":"4109","obj":"Tax:1335626"},{"id":"A4124","pred":"tao:has_database_id","subj":"4124","obj":"Gene:6999"},{"id":"A4126","pred":"tao:has_database_id","subj":"4126","obj":"Tax:11309"},{"id":"A4127","pred":"tao:has_database_id","subj":"4127","obj":"MESH:C041747"},{"subj":"4109","pred":"source","obj":"LitCovid-PubTator"},{"subj":"4124","pred":"source","obj":"LitCovid-PubTator"},{"subj":"4126","pred":"source","obj":"LitCovid-PubTator"},{"subj":"4127","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#93ec9e","default":true}]}]}}